CRL

Charles River Laboratories

$156.98

+0.3 (+0.19%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 19.08.2025
$168.75
(+7.5%)
Strong Buy: 0
Buy: 5
Hold: 12
Sell: 1
Strong Sell: 0
Description:
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Exchange:
NYSE
Country:
USA
Sector:
TRADE & SERVICES
Industry:
SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address:
251 BALLARDVALE ST, WILMINGTON, MA, US
Fiscal year end:
December
Market capitalization:
$7.71 Billion
EBITDA:
$956 Million
PERatio:
0.0
EPS:
-1.3
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.481

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Earnings calender

Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
+119%
How much will you get:
$2,186
Prices dates:
31-07-2015: $77.62 and 31-07-2025: $169.64